Next, in the retrospective analysis comparing B-ALL paired samples (before/after anti-CD19 immunotherapy), we observed loss or significant CD19 downregulation in blasts isolated from 16 patients (Supplementary Fig. 4C). The gene discussed is CD19; the disease is acute lymphoblastic leukemia.